Log in or Sign up for Free to view tailored content for your specialty!
Glaucoma News
VIDEO: Femtosecond laser trabeculotomy shows pressure reduction at 3 years
BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Richard Lewis, MD, speaks about femtosecond laser image-guided high-precision trabeculotomy, or FLigHT.
VIDEO: Genomics, AI will work hand in hand for future of glaucoma management
BARCELONA, Spain — The future of glaucoma management will be enabled by AI and genomics, according to a speaker at Glaucoma Day during the European Society of Cataract and Refractive Surgeons meeting.
VIDEO: Omni system with cataract surgery shows long-term IOP reduction
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Noureen Khan, MD, of Northern Virginia Ophthalmology Associates discusses 36-month results from the GEMINI study.
Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmology community mourns loss of Stefano Gandolfi, MD
Stefano Gandolfi, MD, a glaucoma specialist and Healio | OSN Europe Edition Board Member, died on Sept. 2 at the age of 64 years.
VIDEO: Elios Vision to launch excimer laser for glaucoma in 2025
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Cari Stone of Elios Vision previews the company’s excimer laser for the treatment of glaucoma.
VIDEO: Omni system shows IOP reduction at 24 months in patients with glaucoma
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Anita Campbell, MD, of Stiles Eyecare Excellence, discusses canaloplasty and trabeculotomy outcomes with the Omni surgical system.
Injectsense reports first human implantation of its IOP sensor
Researchers successfully completed the first human implantation of a remote IOP sensor manufactured by Injectsense, according to a press release from the company.
Is it time to shift from drops to interventional glaucoma?
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
Visiox Pharmaceuticals merges with Ocuvex Therapeutics
Visiox Pharmaceuticals has entered into a definitive merger agreement with Ocuvex Therapeutics, according to a press release.
VIDEO: Minimal IOP changes seen with aflibercept 8 mg or 2 mg at 48 weeks
In this Healio Video Perspective from the ASRS meeting, Jordana G. Fein, MD, MS, of Retina Group of Washington discusses IOP outcomes in patients with diabetic macular edema who were treated with aflibercept 8 mg or aflibercept 2 mg.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read